Burnett Patrick

SEC Form 4 insider
See Remarks · Arcutis Biotherapeutics, Inc. ($ARQT)
1 thesis · first seen Aug 14, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d1100%+1.4%+1.4%
3d1100%+1.4%+1.4%
1w111100%-1.9%-1.9%
1m111100%-7.5%-7.5%
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ARQTSEC Form 4bearish
Sold 15,000 @ $26.33 avg · $394,897 · 2026-08-11

Form 4: Burnett Patrick sold ARQT

Burnett Patrick (See Remarks at Arcutis Biotherapeutics, Inc.) reported an open-market sale of 15,000 shares of ARQT at an average $26.33, roughly $394,897, in a Form 4 filed 2026-08-13.

At post $25.83Now $24.94-3.5% since postedas of Aug 24, 1:28 PM ET
1d+1.4%
3d+1.4%
1w-1.9%
1m-7.5%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.